Skip to content

Early Screening Mechanism and Evaluation of Neonatal Hyperbilirubinemia based on the Mobile APP

Early Screening Mechanism and Evaluation of Neonatal Hyperbilirubinemia based on the Mobile APP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049567
Enrollment
Unknown
Registered
2021-08-03
Start date
2019-08-01
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Hyperbilirubinemia

Interventions

intervention group:the family-doctor joint screening mode
control group:the family self-help screening mode

Sponsors

Hainan Women and Children’s Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
17 Years to 46 Years

Inclusion criteria

Inclusion criteria: 1) The maternal and newborn are healthy at discharge, and meet the discharge standard judged by doctor; 2) The puerpera should be at least 16 years old, and have clear cognition, understanding and communication skills; 3) The puerpera or their family members should own a smartphone and have access to jaundice monitoring apps; 4) Not participating in other studies that may affect the results of this experiment; 5) Sign the informed consent and participate in the study voluntarily.

Exclusion criteria

Exclusion criteria: 1) The puerpera who give birth to multiple children (such as twins); 2) The newborn has congenital disease, perinatal asphyxia, neonatal infection, hemolytic disease or other serious organic damage and is readmitted to hospital;

Design outcomes

Primary

MeasureTime frame
Neonatal readmission rate due to jaundice;

Secondary

MeasureTime frame
Maternal anxiety score due to neonatal jaundice;

Countries

China

Contacts

Public ContactFan Linchun

Maternal and Child Health Hospital of Hainan Province

flc007@hainmc.edu.cn+86 18689852199

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026